Skip to content

Clinical trials

Terminated Bronchiolitis Obliterans Syndrome trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Bronchiolitis Obliterans Syndrome Status: Terminated Country / region: United States Clear all

39 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20071
20082
20091
20103
20113
20133
20144
20151
20163
20182
20196
20203
20212
20221
20231
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated39

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Incyte Corporation3
Dana-Farber Cancer Institute2
Gilead Sciences2
M.D. Anderson Cancer Center2
National Cancer Institute (NCI)2
Pfizer2
University of Utah2
APT Pharmaceuticals, Inc.1
Alexion Pharmaceuticals, Inc.1
Algos Clinical Development Thomas L. Yearwood, MD, PhD1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Bronchiolitis Obliterans Syndrome39
Graft vs Host Disease5
Leukemia4
Bronchiolitis Obliterans3
Pain3
Leukemia, Lymphocytic, Chronic, B-Cell2
Leukemia, Myelogenous, Chronic, BCR-ABL Positive2
Back Pain1
Breast Neoplasms1
Cluster Headache1

Trials

Showing 1 to 25 of 39. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.